Key points are not available for this paper at this time.
Check for updatesThe critical role of biomarkersA key pillar of healthcare's journey towards precision medicine has been the proliferation and development of biomarkers to detect, monitor and manage disease.Over the last fifty years, healthcare has seen a rapid acceleration in the discovery of traditional biomarkers for a variety of conditions, including cancer, namely Carcinoembryonic antigen (CEA), and in the 1980s, CA15-3 for breast cancer 1 (Fig. 1).Biomarkers remain a crucial source of data and insight for early detection and diagnosis, assessing the response of treatment and prognosis 1,2 .However, with both the complexity and increasing demands for healthcare, research is increasingly exporting novel opportunities that augment and build upon traditional biomarker approaches 2,3 .
Dylan Powell (Sat,) studied this question.